collection
MENU ▼
Read by QxMD icon Read
search

Bronchiectasis bible

shared collection
14 papers 0 to 25 followers
By Jason Mann No BS pulmonary critical care fellow
https://www.readbyqxmd.com/read/27134122/recommendations-for-aetiological-diagnosis-of-bronchiectasis
#1
(no author information available yet)
The number of bronchiectasis diagnoses has increased in the last two decades due to several factors. Research carried out over the last years showed that an aetiological diagnosis could change the approach and treatment of a relevant percentage of patients and consequently the prognosis. Currently, systematic investigation into aetiology, particularly of those disorders that can be subject to specific treatment, is recommended. Given the complexity of the aetiological diagnosis, the Pulmonology Portuguese Society Bronchiectasis Study Group assembled a working group which prepared a document to guide and standardize the aetiologic investigation based on available literature and its own expertise...
July 2016: Revista Portuguesa de Pneumologia
https://www.readbyqxmd.com/read/26568240/update-in-bronchiectasis-2014
#2
Bravein Amalakuhan, Diego J Maselli, Miguel A Martinez-Garcia
No abstract text is available yet for this article.
November 15, 2015: American Journal of Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25588439/chronic-suppurative-lung-disease-and-bronchiectasis-in-children-and-adults-in-australia-and-new-zealand-thoracic-society-of-australia-and-new-zealand-guidelines
#3
Anne B Chang, Scott C Bell, Paul J Torzillo, Paul T King, Graeme P Maguire, Catherine A Byrnes, Anne E Holland, Peter O'Mara, Keith Grimwood
No abstract text is available yet for this article.
January 19, 2015: Medical Journal of Australia
https://www.readbyqxmd.com/read/25620629/efficacy-and-safety-of-long-term-inhaled-antibiotic-for-patients-with-noncystic-fibrosis-bronchiectasis-a-meta-analysis
#4
Jia-Wei Yang, Li-Chao Fan, Hai-Wen Lu, Xia-Yi Miao, Bei Mao, Jin-Fu Xu
BACKGROUND AND AIMS: The evidence supported the use of nebulized antibiotics in non-cystic fibrosis (non-CF) bronchiectasis is indefinite. A meta-analysis was performed to determine the efficacy and safety of long-term inhaled antibiotics for patients with non-CF bronchiectasis. METHODS: PubMed, Embase, Web of Science and Cochrane Library databases were searched up to March 20, 2014. Reduction of sputum bacterial density, eradication of sputum Pseudomonas aeruginosa, the risk of exacerbations and other clinical outcomes related to inhalation treatment were analyzed...
January 26, 2015: Clinical Respiratory Journal
https://www.readbyqxmd.com/read/22211147/bronchiectasis-diagnosis-and-treatment
#5
REVIEW
Jessica Rademacher, Tobias Welte
BACKGROUND: Radiologically evident bronchiectasis is seen in 30% to 50% of patients with advanced chronic obstructive pulmonary disease (COPD). As COPD is now becoming more common around the world, bronchiectasis is as well. METHODS: We review pertinent articles published before May 2011 that were retrieved by a selective PubMed search. RESULTS: The principles of treatment of bronchiectasis in patients who do not have cystic fibrosis ("non-CF bronchiectasis") are derived from the treatment of other diseases: secretolytic and anti-infectious treatment are given as in cystic fibrosis, while anti-obstructive treatment is given as in COPD...
December 2011: Deutsches Ärzteblatt International
https://www.readbyqxmd.com/read/24232697/multidimensional-approach-to-non-cystic-fibrosis-bronchiectasis-the-faced-score
#6
MULTICENTER STUDY
Miguel Á Martínez-García, Javier de Gracia, Monserrat Vendrell Relat, Rosa-Maria Girón, Luis Máiz Carro, David de la Rosa Carrillo, Casilda Olveira
Bronchiectasis is a multidimensional disease and, therefore, its severity or prognosis cannot be adequately quantified by analysing one single variable. The objective of the present study was to develop a multidimensional score that classifies the severity of bronchiectasis according to its prognosis. This is an observational multicentre study including 819 patients diagnosed with non-cystic fibrosis bronchiectasis using high-resolution computed tomography. 397 subjects were selected at random to construct the score while the remaining 422 were used for its validation...
May 2014: European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology
https://www.readbyqxmd.com/read/25826593/inhaled-antibiotics-in-cystic-fibrosis-cf-and-non-cf-bronchiectasis
#7
REVIEW
George T P Tay, David W Reid, Scott C Bell
Bronchiectasis is a pathological diagnosis describing dilatation of the airways and is characterized by chronic lung sepsis. Bronchiectasis has multiple etiologies, but is usually considered in terms of whether it is due to the genetic disorder cystic fibrosis (CF) or secondary to other causes (non-CF bronchiectasis, NCFB). Inhaled antibiotics are used in bronchiectasis to suppress bacterial pathogens and reduce long-term lung function decline. The majority of the literature on inhaled antibiotics comes from studies on CF where the dominant bacterial pathogen in the airway is usually Pseudomonas aeruginosa...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826592/airway-clearance-strategies-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis
#8
Eleanor Main, Lizzie Grillo, Sarah Rand
Many patients with cystic fibrosis (CF) and non-CF bronchiectasis present with common symptoms in clinical domains that appear to benefit from airway clearance strategies. These symptoms include chronic productive cough, retention of excessive, purulent mucus in dilated airways, impairment of normal mucociliary clearance (MCC), atelectasis, breathlessness, fatigue, respiratory inflammation, fever, infection, and airflow obstruction. Airway clearance strategies may involve singular and focused interventions for the purpose of removing secretions and improving lung recruitment and gas exchange in patients with atelectasis...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826590/the-microbiome-and-emerging-pathogens-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis
#9
REVIEW
Heather Green, Andrew M Jones
Chronic pulmonary sepsis is the predominant cause of morbidity for patients with cystic fibrosis (CF) and non-CF bronchiectasis. Previously it was thought that respiratory infection in these patients was mostly limited to a very small number of typical pathogens; however, in recent years there have been increasing reports of infection with other emerging potential pathogens including Burkholderia, Stenotrophomonas, Achromobacter, Ralstonia, Pandoraea, nontuberculous mycobacteria, and fungal species. Furthermore, culture-independent methodologies have established that the lungs of patients with CF and non-CF bronchiectasis comprise mixed microbiological communities of aerobic and anaerobic bacteria, fungal and viral species, collectively referred to as the lung microbiome...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826589/nontuberculous-mycobacteria-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis
#10
REVIEW
In Kwon Park, Kenneth N Olivier
Increasing numbers of cystic fibrosis (CF) and non-CF bronchiectasis patients are affected by pulmonary nontuberculous mycobacteria (NTM) infection worldwide. Two species of NTM account for up to 95% of the pulmonary NTM infections: Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC). Diagnosis of pulmonary NTM infection is based on criteria specified in the 2007 American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) guidelines. While many initial positive cultures do not progress to active NTM disease, even a single positive NTM sputum culture obtained from higher risk groups such as classic CF or older women with bronchiectasis and very low body mass index should be closely monitored for progressive disease...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826588/fungi-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis
#11
REVIEW
Richard B Moss
Bronchiectasis is a pathologic bronchial dilatation with loss of function that can result from multiple inflammatory and infectious injuries to the conducting airways of the lung. Molds, particularly the filamentous fungus Aspergillus fumigatus, have been implicated as a common cause of both cystic fibrosis (CF) and non-CF bronchiectasis, the latter primarily in patients with severe asthma. The pathogenesis of mold-associated bronchiectasis is usually due to atopic sensitization to mold allergens in the presence of active chronic endobronchial fungal infection with host innate and adaptive immune deviation to a Th2-dominated inflammation, a condition known as allergic bronchopulmonary aspergillosis (ABPA) (or allergic bronchopulmonary mycosis if a non-Aspergillus mold is implicated)...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826587/imaging-in-cystic-fibrosis-and-non-cystic-fibrosis-bronchiectasis
#12
REVIEW
Jonathan D Dodd, Lisa P Lavelle, Aurelie Fabre, Darragh Brady
Bronchiectasis is defined as a permanent and progressive dilation of the airways, typically as a result of inflammation, infection, and subsequent repair. It typically presents with chronic cough, suppurative sputum production, and airway dilation. High-resolution computed tomography (HRCT) is now well established as the primary imaging tool for its investigation. Cystic fibrosis (CF) remains the most common autosomal recessive inherited disorder worldwide and its pulmonary hallmark is bronchiectasis. Although CF and non-CF bronchiectasis are different clinical entities, they are typically imaged using HRCT and share many imaging aspects, and also some differences...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826586/genotypes-and-phenotypes-in-cystic-fibrosis-and-cystic-fibrosis-transmembrane-regulator-related-disorders
#13
REVIEW
Cristina Bombieri, Manuela Seia, Carlo Castellani
Cystic fibrosis (CF) is characterized by remarkable variability in severity, rate of disease progression, and organ involvement. In spite of the considerable amount of data collected on the relationship between genotype and phenotype in CF, this is still a challenging matter of debate. Barriers to the interpretation of this connection are the large number of mutations in the CF transmembrane regulator (CFTR) gene, the difficulties in attributing several of them to a specific mode of dysfunction, and a limited number of the almost 2,000 mutations so far detected, which have been clinically annotated...
April 2015: Seminars in Respiratory and Critical Care Medicine
https://www.readbyqxmd.com/read/25826585/primary-ciliary-dyskinesia
#14
REVIEW
Jason Lobo, Maimoona A Zariwala, Peadar G Noone
Primary ciliary dyskinesia (PCD) is an autosomal recessive disorder of cilia structure, function, and biogenesis leading to chronic infections of the respiratory tract, fertility problems, and disorders of organ laterality. The diagnosis can be challenging, using traditional tools such as characteristic clinical features, ciliary function, and ultrastructural defects and newer screening tools such as nasal nitric oxide levels and genetic testing add to the diagnostic algorithm. There are 32 known PCD-causing genes, and in the future, comprehensive genetic testing may screen young infants before developing symptoms, thus improving survival...
April 2015: Seminars in Respiratory and Critical Care Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"